AJDRAJNR - American Journal of Neuroradiology

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tintoré, M.
Right arrow Articles by Montalban, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tintoré, M.
Right arrow Articles by Montalban, X.

ARTICLE

Isolated Demyelinating Syndromes: Comparison of Different MR Imaging Criteria to Predict Conversion to Clinically Definite Multiple Sclerosis

Mar Tintoré,a, Alex Roviraa, Maria J. Martíneza, Jordi Rioa, Pablo Díaz-Villosladaa, Luis Brievaa, Cecilia Borrása, Elisenda Grivéa, Jaume Capelladesa and Xavier Montalbana

a From the Unit of Clinical Neuroimmunology, Department of Neurology (M.T., J.R., P.D.-V., L.B., C.B., X.M.), and the Magnetic Resonance Unit (I.D.I.), Department of Radiology (A.R., M.J.M., E.G., J.C.), Vall d'Hebron University Hospitals, Barcelona, Spain.

BACKGROUND AND PURPOSE: Various authors have developed criteria to classify MR imaging findings that suggest the possibility of multiple sclerosis. The purpose of this study was to evaluate and compare the capacity of three sets of MR imaging criteria for predicting the conversion of isolated demyelinating syndromes to clinically definite multiple sclerosis.

METHODS: Seventy patients with clinically isolated neurologic symptoms suggestive of multiple sclerosis were prospectively studied with MR imaging. The MR imaging findings were evaluated by two independent neuroradiologists who were blinded to clinical follow-up data. Based on the clinical outcome at follow-up (presence of a second attack that established clinically definite multiple sclerosis), the sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of the criteria proposed by Paty et al, Fazekas et al, and Barkhof et al were calculated.

RESULTS: Clinically definite multiple sclerosis developed in 22 (31%) patients after a mean follow-up time of 28.3 months. The criteria proposed by Paty et al and those proposed by Fazekas et al showed identical results: sensitivity, 86%; specificity, 54%; accuracy, 64%; positive predictive value, 46%; and negative predictive value, 89%. The criteria proposed by Barkhof et al showed the following: sensitivity, 73%; specificity, 73%; accuracy, 73%; positive predictive value, 55%; and negative predictive value, 85%.

CONCLUSION: The four dichotomized MR imaging parameters proposed by Barkhof et al are more specific and accurate than the criteria proposed by Paty et al or Fazekas et al for predicting conversion to clinically definite multiple sclerosis.




This article has been cited by other articles:


Home page
NeurologyHome page
X. Montalban, M. Tintore, J. Swanton, F. Barkhof, F. Fazekas, M. Filippi, J. Frederiksen, L. Kappos, J. Palace, C. Polman, et al.
MRI criteria for MS in patients with clinically isolated syndromes
Neurology, February 2, 2010; 74(5): 427 - 434.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
R. Pelayo, X. Montalban, T. Minoves, D. Moncho, J. Rio, C. Nos, C. Tur, J. Castillo, A. Horga, M. Comabella, et al.
Do multimodal evoked potentials add information to MRI in clinically isolated syndromes?
Multiple Sclerosis, January 1, 2010; 16(1): 55 - 61.
[Abstract] [PDF]


Home page
Mult SclerHome page
M. Nakamura, H. Houzen, M. Niino, K. Tanaka, and H. Sasaki
Relationship between Barkhof criteria and the clinical features of multiple sclerosis in northern Japan
Multiple Sclerosis, December 1, 2009; 15(12): 1450 - 1458.
[Abstract] [PDF]


Home page
Mult SclerHome page
X. Montalban, J. Sastre-Garriga, M. Filippi, Z. Khaleeli, N. Tellez, M. Vellinga, C. Tur, B. Brochet, F. Barkhof, M. Rovaris, et al.
Primary progressive multiple sclerosis diagnostic criteria: a reappraisal
Multiple Sclerosis, December 1, 2009; 15(12): 1459 - 1465.
[Abstract] [PDF]


Home page
NeurologyHome page
N. Jafari, K. L. Kreft, H. Z. Flach, A. C.J.W. Janssens, and R. Q. Hintzen
Callosal lesion predicts future attacks after clinically isolated syndrome
Neurology, December 1, 2009; 73(22): 1837 - 1841.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
B. Moraal, C. Pohl, B. M. J. Uitdehaag, C. H. Polman, G. Edan, M. S. Freedman, H.-P. Hartung, L. Kappos, D. H. Miller, X. Montalban, et al.
Magnetic Resonance Imaging Predictors of Conversion to Multiple Sclerosis in the BENEFIT Study
Arch Neurol, November 1, 2009; 66(11): 1345 - 1352.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
J. Young, S. Quinn, M. Hurrell, and B. Taylor
Clinically isolated acute transverse myelitis: prognostic features and incidence
Multiple Sclerosis, November 1, 2009; 15(11): 1295 - 1302.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C-P Lo, H-W Kao, S-Y Chen, C-J Hsueh, W-C Lin, W-L Hsu, D-K Wu, and G-C Liu
Prediction of conversion from clinically isolated syndrome to clinically definite multiple sclerosis according to baseline MRI findings: comparison of revised McDonald criteria and Swanton modified criteria
J. Neurol. Neurosurg. Psychiatry, October 1, 2009; 80(10): 1107 - 1109.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
D. Goodin and D. Bates
Review: Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode
Multiple Sclerosis, October 1, 2009; 15(10): 1175 - 1182.
[Abstract] [PDF]


Home page
Mult SclerHome page
A Siva, S Saip, A Altintas, A Jacob, B. Keegan, and O. Kantarci
Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease
Multiple Sclerosis, August 1, 2009; 15(8): 918 - 927.
[Abstract] [PDF]


Home page
Mult SclerHome page
J Rio, J Castillo, A Rovira, M Tintore, J Sastre-Garriga, A Horga, C Nos, M Comabella, X Aymerich, and X Montalban
Measures in the first year of therapy predict the response to interferon {beta} in MS
Multiple Sclerosis, July 1, 2009; 15(7): 848 - 853.
[Abstract] [PDF]


Home page
Arch NeurolHome page
C. Lebrun, C. Bensa, M. Debouverie, S. Wiertlevski, D. Brassat, J. de Seze, L. Rumbach, J. Pelletier, P. Labauge, B. Brochet, et al.
Association Between Clinical Conversion to Multiple Sclerosis in Radiologically Isolated Syndrome and Magnetic Resonance Imaging, Cerebrospinal Fluid, and Visual Evoked Potential: Follow-up of 70 Patients
Arch Neurol, July 1, 2009; 66(7): 841 - 846.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
A. Rovira, J. Swanton, M. Tintore, E. Huerga, F. Barkhof, M. Filippi, J. L. Frederiksen, A. Langkilde, K. Miszkiel, C. Polman, et al.
A Single, Early Magnetic Resonance Imaging Study in the Diagnosis of Multiple Sclerosis
Arch Neurol, May 1, 2009; 66(5): 587 - 592.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
M. Freedman, J Laks, N Dotan, R. Altstock, A Dukler, and C. Sindic
Anti-{alpha}-glucose-based glycan IgM antibodies predict relapse activity in multiple sclerosis after the first neurological event
Multiple Sclerosis, April 1, 2009; 15(4): 422 - 430.
[Abstract] [PDF]


Home page
NeurologyHome page
B. L. Banwell
Into the looking glass: Predicting MS in children experiencing a first demyelinating event
Neurology, September 23, 2008; 71(13): 962 - 963.
[Full Text] [PDF]


Home page
Mult SclerHome page
C Tur, M Tintore, A Rovira, C Nos, J Rio, N Tellez, I Galan, H Perkal, M Comabella, J Sastre-Garriga, et al.
Very early scans for demonstrating dissemination in time in multiple sclerosis
Multiple Sclerosis, June 1, 2008; 14(5): 631 - 635.
[Abstract] [PDF]


Home page
Mult SclerHome page
M. Simo, P. Barsi, and Z. Aranyi
Predictive role of evoked potential examinations in patients with clinically isolated optic neuritis in light of the revised McDonald criteria
Multiple Sclerosis, May 1, 2008; 14(4): 472 - 478.
[Abstract] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C Lebrun, C Bensa, M Debouverie, J De Seze, S Wiertlievski, B Brochet, P Clavelou, D Brassat, P Labauge, E Roullet, et al.
Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profile
J. Neurol. Neurosurg. Psychiatry, February 1, 2008; 79(2): 195 - 198.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M.P. Wattjes, M. Harzheim, G.G. Lutterbey, L. Klotz, H.H. Schild, and F. Traber
Axonal Damage But No Increased Glial Cell Activity in the Normal-Appearing White Matter of Patients with Clinically Isolated Syndromes Suggestive of Multiple Sclerosis Using High-Field Magnetic Resonance Spectroscopy
AJNR Am. J. Neuroradiol., September 1, 2007; 28(8): 1517 - 1522.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
R. Pelayo, M. Tintore, A. Rovira, J. Rio, C. Nos, E. Grive, N. Tellez, M. Comabella, and X. Montalban
Polyregional and hemispheric syndromes: a study of these uncommon first attacks in a CIS cohort
Multiple Sclerosis, July 1, 2007; 13(6): 731 - 736.
[Abstract] [PDF]


Home page
NeurologyHome page
B. Banwell, M. Shroff, J. M. Ness, D. Jeffery, S. Schwid, B. Weinstock-Guttman, and for the International Pediatric MS Study Group
MRI features of pediatric multiple sclerosis
Neurology, April 17, 2007; 68(16_suppl_2): S46 - S53.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Puccioni-Sohler, Y. Yamano, M. Rios, S.M.F. Carvalho, C. C.F. Vasconcelos, R. Papais-Alvarenga, and S. Jacobson
Differentiation of HAM/TSP from patients with multiple sclerosis infected with HTLV-I
Neurology, January 16, 2007; 68(3): 206 - 213.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M.P. Wattjes, G.G. Lutterbey, J. Gieseke, F. Traber, L. Klotz, S. Schmidt, and H.H. Schild
Double Inversion Recovery Brain Imaging at 3T: Diagnostic Value in the Detection of Multiple Sclerosis Lesions
AJNR Am. J. Neuroradiol., January 1, 2007; 28(1): 54 - 59.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
M. Tintore, A. Rovira, J. Rio, C. Nos, E. Grive, N. Tellez, R. Pelayo, M. Comabella, J. Sastre-Garriga, and X. Montalban
Baseline MRI predicts future attacks and disability in clinically isolated syndromes.
Neurology, September 26, 2006; 67(6): 968 - 972.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. Imrell, A.-M. Landtblom, J. Hillert, and T. Masterman
Multiple sclerosis with and without CSF bands: Clinically indistinguishable but immunogenetically distinct.
Neurology, September 26, 2006; 67(6): 1062 - 1064.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M.P. Wattjes, M. Harzheim, C.K. Kuhl, J. Gieseke, S. Schmidt, L. Klotz, T. Klockgether, H.H. Schild, and G.G. Lutterbey
Does High-field MR Imaging Have an Influence on the Classification of Patients with Clinically Isolated Syndromes According to Current Diagnostic MR Imaging Criteria for Multiple Sclerosis?
AJNR Am. J. Neuroradiol., September 1, 2006; 27(8): 1794 - 1798.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
J K Swanton, K Fernando, C M Dalton, K A Miszkiel, A J Thompson, G T Plant, and D H Miller
Modification of MRI criteria for multiple sclerosis in patients with clinically isolated syndromes
J. Neurol. Neurosurg. Psychiatry, July 1, 2006; 77(7): 830 - 833.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
M. Inglese
Multiple sclerosis: new insights and trends.
AJNR Am. J. Neuroradiol., May 1, 2006; 27(5): 954 - 957.
[Full Text] [PDF]


Home page
Mult SclerHome page
J Bruna, S Martinez-Yelamos, A Martinez-Yelamos, F Rubio, and T Arbizu
Idiopathic acute transverse myelitis: a clinical study and prognostic markers in 45 cases
Multiple Sclerosis, April 1, 2006; 12(2): 169 - 173.
[Abstract] [PDF]


Home page
NeurologyHome page
J. Masjuan, J. C. Alvarez-Cermeno, N. Garcia-Barragan, M. Diaz-Sanchez, M. Espino, M. C. Sadaba, P. Gonzalez-Porque, J. M. San Millan, and L. M. Villar
Clinically isolated syndromes: A new oligoclonal band test accurately predicts conversion to MS
Neurology, February 28, 2006; 66(4): 576 - 578.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S A Trip and D H Miller
Imaging in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, September 1, 2005; 76(suppl_3): iii11 - iii18.
[Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
J Zajicek
Diagnosis and disease modifying treatments in multiple sclerosis
Postgrad. Med. J., September 1, 2005; 81(959): 556 - 561.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
C. H Polman, J. S Wolinsky, and S. C Reingold
Multiple sclerosis diagnostic criteria: three years later
Multiple Sclerosis, February 1, 2005; 11(1): 5 - 12.
[Abstract] [PDF]


Home page
NeurologyHome page
R. Bakshi, G. J. Hutton, J. R. Miller, and E.-W. Radue
The use of magnetic resonance imaging in the diagnosis and long-term management of multiple sclerosis
Neurology, December 14, 2004; 63(11_suppl_5): S3 - S11.
[Abstract] [Full Text]


Home page
BrainHome page
Y. Mikaeloff, C. Adamsbaum, B. Husson, L. Vallee, G. Ponsot, C. Confavreux, M. Tardieu, S. Suissa, and the KIDMUS Study Group on Radiology
MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood
Brain, September 1, 2004; 127(9): 1942 - 1947.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
C. D. Hahn, M. M. Shroff, S. I. Blaser, and B. L. Banwell
MRI criteria for multiple sclerosis: Evaluation in a pediatric cohort
Neurology, March 9, 2004; 62(5): 806 - 808.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
S Goffette, M Schluep, H Henry, T Duprez, and C J M Sindic
Detection of oligoclonal free kappa chains in the absence of oligoclonal IgG in the CSF of patients with suspected multiple sclerosis
J. Neurol. Neurosurg. Psychiatry, February 1, 2004; 75(2): 308 - 310.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
J. Sastre-Garriga, M. Tintore, A. Rovira, C. Nos, J. Rio, A. J. Thompson, and X. Montalban
Specificity of Barkhof Criteria in Predicting Conversion to Multiple Sclerosis When Applied to Clinically Isolated Brainstem Syndromes
Arch Neurol, February 1, 2004; 61(2): 222 - 224.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. C.J. Bot, F. Barkhof, C. H. Polman, G.J. L. a Nijeholt, V. de Groot, E. Bergers, H. J. Ader, and J. A. Castelijns
Spinal cord abnormalities in recently diagnosed MS patients: Added value of spinal MRI examination
Neurology, January 27, 2004; 62(2): 226 - 233.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
C M Dalton, P A Brex, K A Miszkiel, K Fernando, D G MacManus, G T Plant, A J Thompson, and D H Miller
Spinal cord MRI in clinically isolated optic neuritis
J. Neurol. Neurosurg. Psychiatry, November 1, 2003; 74(11): 1577 - 1580.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
J. H. Simon and A. J. Thompson
Is multiple sclerosis still a clinical diagnosis?
Neurology, September 9, 2003; 61(5): 596 - 597.
[Full Text] [PDF]


Home page
NeurologyHome page
E. M. Frohman, D. S. Goodin, P. A. Calabresi, J. R. Corboy, P. K. Coyle, M. Filippi, J. A. Frank, S. L. Galetta, R. I. Grossman, K. Hawker, et al.
The utility of MRI in suspected MS: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
Neurology, September 9, 2003; 61(5): 602 - 611.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. Villoslada, C. Juste, M. Tintore, V. Llorenc, G. Codina, P. Pozo-Rosich, and X. Montalban
The immune response against herpesvirus is more prominent in the early stages of MS
Neurology, June 24, 2003; 60(12): 1944 - 1948.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
J Sastre-Garriga, M Tintore, A Rovira, E Grive, I Pericot, M Comabella, A J Thompson, and X Montalban
C onversion to multiple sclerosis after a clinically isolated syndrome of the brainstem: cranial magnetic resonance imaging, cerebrospinal fl uid and neurophysiological findings
Multiple Sclerosis, February 1, 2003; 9(1): 39 - 43.
[Abstract] [PDF]


Home page
NeurologyHome page
M. Tintore, A. Rovira, J. Rio, C. Nos, E. Grive, J. Sastre-Garriga, I. Pericot, E. Sanchez, M. Comabella, and X. Montalban
New diagnostic criteria for multiple sclerosis: Application in first demyelinating episode
Neurology, January 14, 2003; 60(1): 27 - 30.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
CHAMPS Study Group
MRI predictors of early conversion to clinically definite MS in the CHAMPS placebo group
Neurology, October 8, 2002; 59(7): 998 - 1005.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
P. O'Connor
Key issues in the diagnosis and treatment of multiple sclerosis: An overview
Neurology, September 24, 2002; 59(90063): S1 - 33.
[Full Text]


Home page
Mult SclerHome page
M. Rovaris, M. Holtmannspotter, M. Rocca, G. Iannucci, M. Codella, B. Viti, A. Campi, G. Comi, T. Yousry, and M. Filippi
Contribution of cervical cord MRI and brain magnetization transfer imaging to the assessment of individual patients with multiple sclerosis: a preliminary study
Multiple Sclerosis, September 1, 2002; 8(1_suppl): 52 - 58.
[Abstract] [PDF]


Home page
Mult SclerHome page
H. McFarland
The emerging role of MRI in multiple sclerosis and the new diagnostic criteria
Multiple Sclerosis, September 1, 2002; 8(1_suppl): 71 - 72.
[PDF]


Home page
NeurologyHome page
L. M. Villar, J. Masjuan, P. Gonzalez-Porque, J. Plaza, M. C. Sadaba, E. Roldan, A. Bootello, and J. C. Alvarez-Cermeno
Intrathecal IgM synthesis predicts the onset of new relapses and a worse disease course in MS
Neurology, August 27, 2002; 59(4): 555 - 559.
[Abstract] [Full Text] [PDF]


Home page
Mult SclerHome page
CHAMPS Study Group
Baseline MRI characteristics of patients at high risk for multiple sclerosis: results from the CHAMPS trial
Multiple Sclerosis, August 1, 2002; 8(4): 330 - 338.
[Abstract] [PDF]


Home page
Mult SclerHome page
P Kapeller, P A Brex, D Chard, C Dalton, C M Griffin, M A McLean, G J. Parker, A J Thompson, and D H Miller
Quantitative 1H MRS imaging 14 years after presenting with a clinically isolated syndrome suggestive of multiple sclerosis
Multiple Sclerosis, June 1, 2002; 8(3): 207 - 210.
[Abstract] [PDF]


Home page
Mult SclerHome page
M Rovaris, M Holtmannspotter, M A Rocca, G Iannucci, M Codella, B Viti, A Campi, G Comi, T A Yousry, and M Filippi
Contribution of cervical cord MRI and brain magnetization transfer imaging to the assessment of individual patients with multiple sclerosis: a preliminary study
Multiple Sclerosis, February 1, 2002; 8(1): 52 - 58.
[Abstract] [PDF]


Home page
Mult SclerHome page
H F McFarland
The emerging role of MRI in multiple sclerosis and the new diagnostic criteria
Multiple Sclerosis, February 1, 2002; 8(1): 71 - 72.
[PDF]


Home page
Mult SclerHome page
M Tintore, A Rovira, L Brieva, E Grive, R Jardi, C Borras, and X Montalban
Isolated demyelinating syndromes: comparison of CSF oligoclonal bands and different MR imaging criteria to predict conversion to CDMS
Multiple Sclerosis, December 1, 2001; 7(6): 359 - 363.
[Abstract] [PDF]


Home page
BrainHome page
R. C. Dale, C. de Sousa, W. K. Chong, T. C. S. Cox, B. Harding, and B. G. R. Neville
Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children
Brain, December 1, 2000; 123(12): 2407 - 2422.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
J. C. J. Bot, F. Barkhof, G. L. a Nijeholt, D. van Schaardenburg, A. E. Voskuyl, H. J. Ader, J. A. L. Pijnenburg, C. H. Polman, B. M. J. Uitdehaag, E. G. J. Vermeulen, et al.
Differentiation of Multiple Sclerosis from Other Inflammatory Disorders and Cerebrovascular Disease: Value of Spinal MR Imaging
Radiology, April 1, 2002; 223(1): 46 - 56.
[Abstract] [Full Text] [PDF]